Revolutionizing ovarian cancer care and prevention for women worldwide
OVCARE is British Columbia’s multi-institutional and multidisciplinary ovarian cancer research group. OVCARE was founded in 2000 and has grown from a small group of researchers and disconnected research projects to a coherent team that is recognized internationally as a leader in the study of ovarian cancer.
The team is funded in part by donations to VGH & UBC Hospital Foundation.
Each year in Canada, over 3100 women will be diagnosed with ovarian cancer and over 1950 will die from their disease.
7 in 10 women die within 5 years of diagnosis
The OVCARE team’s goal is to decrease cancer mortality from all gynecological cancers by 50% in 20 years
Disease Types: In 2008, OVCARE researchers discovered that ovarian cancer is not a single disease but multiple, distinct disease types. This has fundamentally changed the way ovarian cancer research is being performed in BC, nationally and around the world.
Fallopian Tube Removal: Most ovarian cancers originate in the fallopian tubes. Knowing this, OVCARE launched the world’s first ovarian cancer prevention program at VGH. This changed the Canadian standard of practice for gynecologic procedures such as hysterectomies and tubal ligations to include, in appropriate cases, the safe removal of the fallopian tubes. This prevents this type of ovarian cancer from ever occurring.
BRCA Gene Mutation: As a result of OVCARE research, women in Canada diagnosed with ovarian cancer undergo testing for BRCA1/2 mutations that are associated with other types of cancer, including breast cancer. Identifying this gene enables risk-reducing interventions for patients and family members, saving further lives.
Innovative research like the work being done by the OVCARE team requires philanthropic support to succeed. You are a vital part of groundbreaking research that has the potential to save lives, not just in BC, but around the world.
We need your help to fund innovative research programs like OVCARE. Donate today.